retatrutide phase 2 trial obesity type 2 diabetes weight loss 2024 hits 28% in 3 Retatrutide TRIUMPH-4 Results: Are We – Retatrutide Shows 28% Weight Loss

A 2025 study reported that AI models trained on OCTA data predicted NPDR worsening in T2DM patients, outperforming traditional grading methods (134)

This study addressed key knowledge gaps by characterizing 48-h post-OCC plasma TMAO pharmacokinetics in high TMAO-producing adults and testing whether a single dose of a polyphenol-rich pomegranate extract alters the dynamic TMAO response rather than fasting levels alone

These things can all seriously affect your physical health

The integration of real-time data can help in adjusting dosages as a patient's condition evolves, ensuring continuous optimization of therapy